Latest Financial Disclosure News

Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.

FirstWave Cloud Technology has landed a two-year, USD250,000 software subscription contract with Mexico’s state-owned development bank Banobras, marking its first major public sector win and debut via Grupo Salinas’ OmniPrinter channel.

Rivco Australia has locked in a $11.7 million, five-year water lease with Kyndalyn Park, significantly expanding its contracted revenue and leased portfolio to 82% starting July 2026.

Metro Mining’s latest JORC update reveals a 69.6 million wet tonne Ore Reserve at Bauxite Hills, reflecting 8.1 million tonnes mined in 2025 with no new resource additions. The high-grade bauxite operation continues as a direct shipping ore mine amid rising silica content concerns.

Australian Clinical Labs has been hit with a class action lawsuit linked to a 2022 cyberattack on Medlab Pathology, alleging breaches of consumer law and duty of care. The company denies the claims and plans a vigorous defence.

African Gold Ltd has secured Supreme Court approval for its share and option schemes under the Montage Gold acquisition, setting a clear path to finalise the takeover by late April.

The ASX has published its latest roster of over 40 entities suspended for more than three months, detailing looming deadlines for overdue reports and trading resumption plans. Failure to meet these could trigger removal from the official list.

Elanor Investors Group has finalised a $125 million recapitalisation with Rockworth Capital Partners, restructuring its debt and setting the stage for expansion in Asia. The move repaid existing facilities and bolstered working capital, while a Singapore acquisition awaits regulatory green light.

Burgundy Diamond Mines has responded to ASX scrutiny over its related-party financing with Choron Holdings, asserting the arrangements were short-term, non-material cash-flow facilities properly disclosed in its half-year accounts.

Carbonxt Group has secured $750,000 through convertible notes from major shareholder Phelbe Pty Ltd, targeting expansion of its Minnesota pellet manufacturing and increasing its New Carbon Processing stake to 48.1%.

Livium has extended its recycling agreement with Sell & Parker by a year, secured an upfront deposit, and is ramping up processing volumes with a new dedicated plant at Campbellfield.

Orthocell has secured approval for its Remplir™ nerve repair device to be used across 221 U.S. military and veterans hospitals, marking a major step in its U.S. commercial expansion. The approval follows clinical validation in conflict zones, positioning Orthocell to deepen penetration into defence healthcare.